300204 舒泰神
已收盘 07-23 15:00:00
资讯
新帖
简况
独家药品概念盘中拉升，舒泰神涨3.59%
市场透视 · 07-17
独家药品概念盘中拉升，舒泰神涨3.59%
舒泰神：多个在研项目推进到临床中后期并获得多项突破性疗法认定
证券之星 · 07-11
舒泰神：多个在研项目推进到临床中后期并获得多项突破性疗法认定
舒泰神股价震荡下行 生物制品板块受关注
金融界 · 07-10
舒泰神股价震荡下行 生物制品板块受关注
舒泰神股价40.50元 公司取得STSA-1002注射液临床研究总结报告
金融界 · 07-09
舒泰神股价40.50元 公司取得STSA-1002注射液临床研究总结报告
单抗概念盘中拉升，舒泰神涨1.26%
市场透视 · 07-09
单抗概念盘中拉升，舒泰神涨1.26%
舒泰神最新公告：取得STSA-1002注射液Ib/II期临床研究总结报告
证券之星 · 07-08
舒泰神最新公告：取得STSA-1002注射液Ib/II期临床研究总结报告
舒泰神上涨5.05%，报42.89元/股
金融界 · 07-03
舒泰神上涨5.05%，报42.89元/股
4397家公司半年被“登门”1.29万次，机构挖掘哪些赛道机会
第一财经 · 07-02
4397家公司半年被“登门”1.29万次，机构挖掘哪些赛道机会
单抗概念盘中拉升，舒泰神涨7.21%
市场透视 · 07-02
单抗概念盘中拉升，舒泰神涨7.21%
独家药品概念盘中拉升，舒泰神涨8.37%
市场透视 · 07-01
独家药品概念盘中拉升，舒泰神涨8.37%
【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。
金融界 · 06-30
【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。
舒泰神：公司2025年半年度报告预计于2025年08月26日披露
证券之星 · 06-27
舒泰神：公司2025年半年度报告预计于2025年08月26日披露
舒泰神股价狂飙380％的魔幻与现实：靠一款未上市新药搅动资本狂欢
微博财经-财道工作室 · 06-26
舒泰神股价狂飙380％的魔幻与现实：靠一款未上市新药搅动资本狂欢
单抗概念盘中拉升，舒泰神涨2.89%
市场透视 · 06-20
单抗概念盘中拉升，舒泰神涨2.89%
舒泰神：公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数
证券之星 · 06-19
舒泰神：公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数
每周股票复盘：舒泰神（300204）因日涨幅达15%再次上榜龙虎榜
证券之星 · 06-13
每周股票复盘：舒泰神（300204）因日涨幅达15%再次上榜龙虎榜
新冠药物概念盘中拉升，舒泰神涨5.39%
市场透视 · 06-13
新冠药物概念盘中拉升，舒泰神涨5.39%
【创新药概念震荡反弹 睿智医药涨超11%】 创新药概念震荡反弹，截至发稿，睿智医药涨超11%，仟源医药、悦康药业、舒泰神、昂立康等跟涨。
金融界 · 06-12
【创新药概念震荡反弹 睿智医药涨超11%】 创新药概念震荡反弹，截至发稿，睿智医药涨超11%，仟源医药、悦康药业、舒泰神、昂立康等跟涨。
中国创新药掘金！一文梳理突破性疗法（BTD）品种
格隆汇 · 06-09
中国创新药掘金！一文梳理突破性疗法（BTD）品种
6月9日舒泰神（300204）龙虎榜数据
证券之星 · 06-09
6月9日舒泰神（300204）龙虎榜数据
加载更多
公司概况
公司名称：
舒泰神(北京)生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-04-15
主营业务：
舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是注射用鼠神经生长因子(苏肽生)、复方聚乙二醇电解质散(IV)(舒泰清)。公司以自主知识产权创新药物，特别是生物药物的研发、生产和营销为主要业务。作为创新型生物制药企业，公司的产业链条完整，拥有较为完善的研发、生产、质量管理、营销以及配套的体系，是国家级高新技术企业。
发行价格：
52.50
{"stockData":{"symbol":"300204","market":"SZ","secType":"STK","nameCN":"舒泰神","latestPrice":43.6,"timestamp":1753254186000,"preClose":45.6,"halted":0,"volume":17567839,"delay":0,"changeRate":-0.0439,"floatShares":472000000,"shares":478000000,"eps":-0.3002,"marketStatus":"已收盘","change":-2,"latestTime":"07-23 15:00:00","open":44,"high":45.5,"low":42.56,"amount":774000000,"amplitude":0.0645,"askPrice":43.61,"askSize":6,"bidPrice":43.6,"bidSize":273,"shortable":0,"etf":0,"ttmEps":-0.3002,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":5,"adr":0,"adjPreClose":45.6,"symbolType":"stock","openAndCloseTimeList":[[1753234200000,1753241400000],[1753246800000,1753254000000]],"highLimit":50.16,"lowLimit":41.04,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":477772555,"isCdr":false,"pbRate":22.85,"roa":"--","roe":"--","epsLYR":-0.3,"committee":0.744966,"marketValue":20831000000,"turnoverRate":0.0372,"status":1,"floatMarketCap":20578000000},"requestUrl":"/m/hq/s/300204","defaultTab":"news","newsList":[{"id":"2552174885","title":"独家药品概念盘中拉升，舒泰神涨3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174885?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:35","pubTimestamp":1752716148,"startTime":"0","endTime":"0","summary":"07月17日，独家药品概念盘中拉升，截至09点35分，独家药品概念整体指数上涨0.52%，报980.560点。从个股上来看，该概念的成分股中，舒泰神涨3.59%，上海凯宝、华润三九、益佰制药涨幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为993.62万，其中华润三九受到资金热捧，主力净流入1598.93万；拉长时间线来看，该板块近20日主力资金净流入-18.88亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093548a44fc901&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093548a44fc901&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0097","BK0012","BK0188","300204","BK0239","BK0070","BK0028","BK0046","BK0077","600594","BK0060","BK0039"],"gpt_icon":0},{"id":"2550670858","title":"舒泰神：多个在研项目推进到临床中后期并获得多项突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2550670858","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550670858?lang=zh_cn&edition=full","pubTime":"2025-07-11 08:40","pubTimestamp":1752194422,"startTime":"0","endTime":"0","summary":"但董事长说今年是最好的一年，其基于什么理由呢舒泰神回复：您好！在2025年4月16日举办的《舒泰神2024年度业绩线上说明会》上，相关信心主要是基于：舒泰神公司已经构建了从药物发现、药理毒理到临床研究的完整团队和系统能力，多个在研项目推进到临床中后期并获得多项突破性疗法认定，医药市场将迎来创新药企业的发展周期等因素；舒泰神公司“以未被满足的临床需求”为核心战略的长期资源聚焦可能即将迎来研发成果转化的未来预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100005696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"gpt_icon":0},{"id":"2550673561","title":"舒泰神股价震荡下行 生物制品板块受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2550673561","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550673561?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:53","pubTimestamp":1752173608,"startTime":"0","endTime":"0","summary":"舒泰神7月10日股价报39.68元，较前一交易日下跌2.02%。盘中最高触及41.86元，最低下探39元，振幅达7.06%，成交金额8.73亿元。该公司属于生物制品行业，专注于创新药和单抗领域。作为北京板块上市公司，舒泰神在创业板上市，总市值约189.58亿元。7月10日早盘，舒泰神曾出现快速反弹，在5分钟内涨幅超过2%，股价一度回升至39.91元。当日主力资金呈现净流出状态，净流出金额2.12万元。风险提示：股市有风险，投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11025351614555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","300204","BK0239","BK0046"],"gpt_icon":0},{"id":"2550465715","title":"舒泰神股价40.50元 公司取得STSA-1002注射液临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2550465715","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550465715?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:53","pubTimestamp":1752083588,"startTime":"0","endTime":"0","summary":"截至2025年7月9日15时22分，舒泰神股价为40.50元，较前一交易日收盘价下跌0.13元，跌幅为0.32%。当日开盘价为40.00元，最高价为41.66元，最低价为39.25元，成交量为246235.0手，成交额为9.96亿元。舒泰神所属生物制品板块，公司专注于生物制药领域，主要从事创新药物的研发、生产和销售。公司公告显示，舒泰神已取得STSA-1002注射液在急性呼吸窘迫综合征患者中的Ib/II期临床研究总结报告。2025年7月9日，舒泰神主力资金净流出2362.33万元，占流通市值比为0.12%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/10015351595900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0046","STSA","BK4007","300204","BK0239"],"gpt_icon":0},{"id":"2550082925","title":"单抗概念盘中拉升，舒泰神涨1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550082925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550082925?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:44","pubTimestamp":1752025469,"startTime":"0","endTime":"0","summary":"07月09日，单抗概念盘中拉升，截至09点44分，单抗概念整体指数上涨0.51%，报2394.600点。从个股上来看，该概念的成分股中，舒泰神涨1.26%，信立泰、恒瑞医药、长春高新涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-1.89亿，其中恒瑞医药受到资金热捧，主力净流入1310.81万；拉长时间线来看，该板块近20日主力资金净流入-38.27亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709094429a69e2ffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709094429a69e2ffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU1064131003.USD","LU1997245177.USD","600276","BK0012","BK0028","BK0239","LU2495084118.USD","LU1969619763.USD","LU1064130708.USD","BK0183","LU0405327494.USD","LU1997244956.HKD","LU1655091616.SGD","LU2488822045.USD","BK0060","LU1328615791.USD","BK0188","BK0046","300204","LU0405327148.USD","LU1997245094.SGD","BK0196","LU2148510915.USD"],"gpt_icon":0},{"id":"2549654596","title":"舒泰神最新公告：取得STSA-1002注射液Ib/II期临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2549654596","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549654596?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:10","pubTimestamp":1751969438,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司取得STSA-1002注射液在急性呼吸窘迫综合征患者中的Ib/II期临床研究总结报告。主要终点指标显示，2个剂量组均短于对照组，次要终点指标28天全因死亡率低剂量组、高剂量组和对照组分别为26.67%、5.88%、40.00%。STSA-1002注射液具有良好的安全性和耐受性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800031893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"gpt_icon":0},{"id":"2548084087","title":"舒泰神上涨5.05%，报42.89元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548084087","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548084087?lang=zh_cn&edition=full","pubTime":"2025-07-03 09:52","pubTimestamp":1751507577,"startTime":"0","endTime":"0","summary":"7月3日，舒泰神盘中上涨5.05%，截至09:52，报42.89元/股，成交3.65亿元，换手率1.87%，总市值204.92亿元。截至3月31日，舒泰神股东户数2.45万，人均流通股1.93万股。2025年1月-3月，舒泰神实现营业收入6321.4万元，同比减少33.45%；归属净利润-233.5万元，同比增长38.05%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/03095251456498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300204","BK0028","BK0046"],"gpt_icon":0},{"id":"2548389120","title":"4397家公司半年被“登门”1.29万次，机构挖掘哪些赛道机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2548389120","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548389120?lang=zh_cn&edition=full","pubTime":"2025-07-02 19:54","pubTimestamp":1751457248,"startTime":"0","endTime":"0","summary":"半年之内，4397家上市公司接待了1.29万次调研，参与机构数量累计高达13.99万家。上半年，13.99万家机构累计进行了1.29万次调研活动，较去年同期的16.66万家的1.38万次调研量有所减少。机械设备行业凭借庞大的市场需求和持续的技术创新，成为机构关注度最高的领域，上半年共有509家上市公司被机构调研，合计次数达1760次，累计参与机构数量近1.82万家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702195639a4cb29c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702195639a4cb29c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300204","LU1051769294.HKD","LU1051768304.USD","LU0823426480.USD","SGXZ49509284.SGD","LU0651947912.USD","LU0359202008.SGD","LU0327786744.USD","LU0823437842.USD","688018","LU1039395188.USD","BK0072","LU0651946864.USD","002273","LU1934453819.USD","IE00BPRC5H50.USD","399300","BK0070","IE00B031HY20.USD","301345","LU1979443071.USD","IE0005HP3H50.USD","301209","LU2148510915.USD","688008","BK0014","BK0279","LU2424517915.HKD","BK0028","BK0046","LU1515016050.SGD","300124","LU0359201612.USD","LU2580892862.HKD","BK0224","LU1023057109.AUD","LU2039709279.SGD","LU1655091616.SGD","688062","LU0650527681.SGD","159982","301029","IE0031814852.USD","IE00B29SXG58.USD","BK0201","IE00B5MMRT66.SGD","300760","LU2495084118.USD","002475","LU2213484517.USD"],"gpt_icon":0},{"id":"2548383702","title":"单抗概念盘中拉升，舒泰神涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548383702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548383702?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:53","pubTimestamp":1751421197,"startTime":"0","endTime":"0","summary":"07月02日，单抗概念盘中拉升，截至09点53分，单抗概念整体指数上涨0.63%，报2375.170点。从个股上来看，该概念的成分股中，舒泰神涨7.21%，华海药业涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为-3440.99万，其中华海药业受到资金热捧，主力净流入3443.65万；拉长时间线来看，该板块近20日主力资金净流入-46.20亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020953179796a5fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020953179796a5fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0012","BK0188","300204","BK0239","BK0046","BK0028","BK0201","600521","BK0070"],"gpt_icon":0},{"id":"2548304799","title":"独家药品概念盘中拉升，舒泰神涨8.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548304799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548304799?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:39","pubTimestamp":1751333970,"startTime":"0","endTime":"0","summary":"07月01日，独家药品概念盘中拉升，截至09点39分，独家药品概念整体指数上涨0.51%，报925.700点。从个股上来看，该概念的成分股中，舒泰神涨8.37%，贵州百灵、甘李药业、君实生物-U涨幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为2203.75万，其中甘李药业受到资金热捧，主力净流入1146.87万；拉长时间线来看，该板块近20日主力资金净流入-27.32亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701093930a7273745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701093930a7273745&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300204","688180","BK0046","BK0239","BK0028"],"gpt_icon":0},{"id":"2547030203","title":"【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030203","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547030203?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:21","pubTimestamp":1751253664,"startTime":"0","endTime":"0","summary":"创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/30112151382528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","603127","BK0028","LU1146622755.USD","06821","300204","159992","BK1141","BK1161","06127","BK0077","002821","03347","BK1191","BK1574","BK0174","300347","LU1328615791.USD","688488","06978","BK0262","LU1820825898.SGD","BK0046","BK0132","BK1576","BK1583","BK0216"],"gpt_icon":0},{"id":"2546834763","title":"舒泰神：公司2025年半年度报告预计于2025年08月26日披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2546834763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546834763?lang=zh_cn&edition=full","pubTime":"2025-06-27 08:48","pubTimestamp":1750985291,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：您好董秘，请问中报什么时候公布？舒泰神回复：您好！公司2025年半年度报告预计于2025年08月26日披露。感谢您对公司的关注，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700007755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300204","BK0239","BK0028"],"gpt_icon":0},{"id":"2546573970","title":"舒泰神股价狂飙380％的魔幻与现实：靠一款未上市新药搅动资本狂欢","url":"https://stock-news.laohu8.com/highlight/detail?id=2546573970","media":"微博财经-财道工作室","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546573970?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:43","pubTimestamp":1750945380,"startTime":"0","endTime":"0","summary":"舒泰神的困境源于核心产品“断档”与创新药研发失利的双重打击。舒泰神敏锐地捕捉到这一市场需求，迅速围绕新冠药物展开了多款创新药的布局。进入2025年，舒泰神的业绩情况依旧不容乐观。在2019年获批临床后，今年6月3日，STSP-0601附条件上市申请正式获国家药品监督管理局受理。2024年，舒泰神研发投入锐减逾六成，研发费用由上年同期的4.48亿元下降至1.62亿元；2025年第一季度，公司的研发费用也同比减少46.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-06-26/doc-infcmkhf3367560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300204","BK0046","BK0028","BK0239"],"gpt_icon":0},{"id":"2544182441","title":"单抗概念盘中拉升，舒泰神涨2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544182441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544182441?lang=zh_cn&edition=full","pubTime":"2025-06-20 09:36","pubTimestamp":1750383419,"startTime":"0","endTime":"0","summary":"06月20日，单抗概念盘中拉升，截至09点36分，单抗概念整体指数上涨0.50%，报2238.580点。从个股上来看，该概念的成分股中，舒泰神涨2.89%，迈威生物-U、誉衡药业、三生国健涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为7.17万，其中恒瑞医药受到资金热捧，主力净流入716.63万；拉长时间线来看，该板块近20日主力资金净流入-76.65亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062009365997873bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062009365997873bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","300204","BK0028","600276","688062","BK0239","688336"],"gpt_icon":0},{"id":"2544184682","title":"舒泰神：公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2544184682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544184682?lang=zh_cn&edition=full","pubTime":"2025-06-19 08:46","pubTimestamp":1750293974,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神06月18日在投资者关系平台上答复投资者关心的问题。请问把带有时间和姓名的股票交易软件持仓截图和身份证一并扫描发送至公司邮箱，可以获知 非定期报告相关时点的股东人数吗？盼你们具体，明确答复。顺祝健康，快乐 【比如截至到2025年6月10日贵公司的股东人数是多少？23舒泰神回复：您好！感谢您对公司的关注，公司将按照信息披露的要求在定期报告中披露相应时间点的股东人数。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900003929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","300204","BK0028"],"gpt_icon":0},{"id":"2543935653","title":"每周股票复盘：舒泰神（300204）因日涨幅达15%再次上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2543935653","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543935653?lang=zh_cn&edition=full","pubTime":"2025-06-14 05:57","pubTimestamp":1749851833,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，舒泰神报收于36.93元，较上周的29.12元上涨26.82%。本周，舒泰神6月13日盘中最高价报37.98元，股价触及近一年最高点。舒泰神当前最新总市值176.44亿元，在化学制药板块市值排名30/150，在两市A股市值排名876/5150。本周关注点交易信息汇总：舒泰神因日涨幅达到15%的前5只证券登上龙虎榜，近5个交易日内第2次上榜交易信息汇总沪深交易所2025年6月9日公布的交易公开信息显示，舒泰神因日涨幅达到15%的前5只证券登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400008593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2543203775","title":"新冠药物概念盘中拉升，舒泰神涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543203775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543203775?lang=zh_cn&edition=full","pubTime":"2025-06-13 09:36","pubTimestamp":1749778619,"startTime":"0","endTime":"0","summary":"06月13日，新冠药物概念盘中拉升，截至09点36分，新冠药物概念整体指数上涨1.00%，报690.910点。从个股上来看，该概念的成分股中，舒泰神涨5.39%，仟源医药、睿智医药、美诺华涨幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-3875.49万，其中博瑞医药受到资金热捧，主力净流入1171.26万；拉长时间线来看，该板块近20日主力资金净流入-34.08亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093659a4a64262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093659a4a64262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2542067552","title":"【创新药概念震荡反弹 睿智医药涨超11%】 创新药概念震荡反弹，截至发稿，睿智医药涨超11%，仟源医药、悦康药业、舒泰神、昂立康等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542067552","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542067552?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:57","pubTimestamp":1749693443,"startTime":"0","endTime":"0","summary":"创新药概念震荡反弹，截至发稿，睿智医药涨超11%，仟源医药、悦康药业、舒泰神、昂立康等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/12095751021133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","BK0239","BK0046","300149","159992","300204","06978","BK0042","300254","BK0114","BK1161","688658","BK1574","BK0077","BK0028"],"gpt_icon":0},{"id":"2542381463","title":"中国创新药掘金！一文梳理突破性疗法（BTD）品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2542381463","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542381463?lang=zh_cn&edition=full","pubTime":"2025-06-09 19:55","pubTimestamp":1749470126,"startTime":"0","endTime":"0","summary":"从热门靶点到全球新靶点、从老牌药企到新兴药企","market":"sg","thumbnail":"https://img3.gelonghui.com/a2903-ed9e8418-5ef2-4a54-b766-f38f7afa9aca.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a2903-ed9e8418-5ef2-4a54-b766-f38f7afa9aca.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2298985","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1515","LU1807302812.USD","LU1226287875.USD","LU1993786604.SGD","BK1583","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","01530","BK1574","BK1161","BK0028","IE00B5MMRT66.SGD","LU0072913022.USD","LU1226287529.USD","688506","BK1191","LU1226288170.HKD","LU1951186391.HKD","LU1960683339.HKD","IE0008368742.USD","LU0067412154.USD","LU1152091754.HKD","06978","LU0501845795.SGD","SG9999004220.SGD","BK1593","LU1226287792.SGD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YT58.USD","02096","LU0140636845.USD","LU1008478684.HKD","IE0008369823.USD","IE00B031HY20.USD","BK0046","300204","IE00B543WZ88.USD","LU0326950275.SGD","BK0239","LU0880133367.SGD","BK1521"],"gpt_icon":1},{"id":"2542993802","title":"6月9日舒泰神（300204）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2542993802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542993802?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:17","pubTimestamp":1749460675,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年6月9日公布的交易公开信息显示，舒泰神因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年6月9日收盘，舒泰神报收于34.94元，上涨19.99%，涨停，换手率14.69%，成交量69.33万手，成交额22.2亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900022078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","300204","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753259992445,"stockEarnings":[{"period":"1week","weight":0.1321},{"period":"1month","weight":0.3032},{"period":"3month","weight":3.2183},{"period":"6month","weight":5.7456},{"period":"1year","weight":6.7157},{"period":"ytd","weight":5.1538}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"舒泰神(北京)生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24509人(较上一季度减少2.85%)","perCapita":"19257股","listingDate":"2011-04-15","address":"北京市大兴区北京经济技术开发区经海二路36号","registeredCapital":"47777万元","survey":" 舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是注射用鼠神经生长因子(苏肽生)、复方聚乙二醇电解质散(IV)(舒泰清)。公司以自主知识产权创新药物，特别是生物药物的研发、生产和营销为主要业务。作为创新型生物制药企业，公司的产业链条完整，拥有较为完善的研发、生产、质量管理、营销以及配套的体系，是国家级高新技术企业。","listedPrice":52.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"舒泰神,300204,舒泰神股票,舒泰神股票老虎,舒泰神股票老虎国际,舒泰神行情,舒泰神股票行情,舒泰神股价,舒泰神股市,舒泰神股票价格,舒泰神股票交易,舒泰神股票购买,舒泰神股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}